Tango Therapeutics, Inc. (NASDAQ:TNGX) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock and pre-funded warrants Announced: about US$600M · US$30 a share · J.P. Morgan +3 Dealers: J.P. Morgan (co-lead), Leerink Partners (co-lead), Cantor (co-lead), Stifel (co-lead) | Jun 10, 2026 |
| Public offering of common stock and pre-funded warrants Announced: about US$210M · US$8.66 a share · Leerink Partners +1 Dealers: Leerink Partners (co-lead), Cantor (co-lead) Buyers: Farallon Capital Management; TCGX; Balyasny Asset Management; Woodline Partners LP; Invus; Adage Capital Management LP; Boxer Capital Management; Logos Capital; Nantahala Capital; accounts advised by T. Rowe Price Investment Management, Inc. | Oct 23, 2025 |
| Private placement of common stock Announced: about US$15M · US$8.66 a share Buyers: Nextech (led the PIPE) | Oct 23, 2025 |